DICERNA PHARMACEUTICALS INC

Profile

Company Names

DICERNA PHARMACEUTICALS INC

Addresses

480 ARSENAL ST. BUILDING 1, SUITE 120, WATERTOWN, MA 02472

Phone Numbers

617 621 8097

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY, OTHER

Year Incorporated:

2006

State Incorporated:

DELAWARE

Total Amount Raised:

$94,050,565.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2013-07-30 
$59,999,937.00 
$63,000,000.00 
$3,000,063.00 
Equity 
2
2010-08-05 
$29,050,628.00 
$29,050,628.00 
$0.00 
Equity 
1
2010-06-17 
$5,000,000.00 
$5,500,000.00 
$500,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DOUGLAS 
 
FAMBROUGH 
EXECUTIVE OFFICER, DIRECTOR
DICERNA PHARMACEUTICALS INC   |  KCAP BIOTECHNOLOGY FUND LP
BRIAN 
K. 
HALAK 
DIRECTOR
DP VIII ASSOCIATES, L.P.   |  DOMAIN PARTNERS VIII, L.P.   |  OPTHERION INC   |  CARTICEPT MEDICAL INC   |  DICERNA PHARMACEUTICALS INC   |  CARTIVA, INC.   |  DOMAIN PARTNERS IX, L.P.   |  ALIMERA SCIENCES INC
STEPHEN 
 
HOFFMAN 
DIRECTOR
DICERNA PHARMACEUTICALS INC   |  ACELRX PHARMACEUTICALS INC   |  COLLEGIUM PHARMACEUTICAL INC   |  GENOCEA BIOSCIENCES, INC.   |  PROTEON THERAPEUTICS INC   |  TRADING BLOCK HOLDINGS, INC.   |  PALLEON PHARMA INC.   |  PALLEON PHARMACEUTICALS INC.   |  BODY + MIND INC.   |  APIC BIO, INC.   |  RYTHERA THERAPEUTICS INC.
JAMES 
C. 
JENSON 
DIRECTOR
DICERNA PHARMACEUTICALS INC
PETER 
 
KOLCHINSKY 
DIRECTOR
RA CAPITAL HEALTHCARE FUND II, L.P.   |  RA CAPITAL HEALTHCARE INTERNATIONAL FUND LTD   |  RA CAPITAL HEALTHCARE FUND LP   |  CELLSCAPE CORP   |  DICERNA PHARMACEUTICALS INC   |  WAVE LIFE SCIENCES PTE LTD   |  CALIMMUNE, INC.   |  LANTOS TECHNOLOGIES, INC.   |  G1 THERAPEUTICS, INC.   |  SOJOURNIX, INC.   |  ADEO HEALTH SCIENCE, INC.   |  RA CAPITAL NEXUS INTERNATIONAL FUND, L.P.   |  RA CAPITAL NEXUS FUND, L.P.   |  VAXESS TECHNOLOGIES, INC.   |  ICOSAVAX, INC.   |  ARS PHARMACEUTICALS, INC.   |  FREENOME HOLDINGS, INC.   |  RA CAPITAL NEXUS INTERNATIONAL FUND III, L.P.   |  RA CAPITAL NEXUS FUND III, L.P.   |  NATURE-S TOOLBOX, INC.   |  RA CAPITAL PLANETARY HEALTH FUND, L.P.   |  RA CAPITAL PLANETARY HEALTH INTERNATIONAL FUND, L.P.   |  TERRESTRIAL BIO, INC.
DENNIS 
 
LANGER 
DIRECTOR
DICERNA PHARMACEUTICALS INC   |  LIGHT SCIENCES ONCOLOGY INC   |  INNOCOLL HOLDINGS, INC.   |  SANCILIO + COMPANY, INC.   |  ALZHEON, INC.   |  SANCILIO PHARMACEUTICALS COMPANY, INC.   |  MYRIAD GENETICS INC   |  QUOIN PHARMACEUTICALS, INC.   |  NEXEOS DIAGNOSTICS, INC.   |  BROOKLYN IMMUNOTHERAPEUTICS, INC.   |  QUOIN PHARMACEUTICALS, LTD.   |  AVICENNA BIOSCIENCES, INC.   |  EMPIRICO INC.
DENNIS 
H. 
LANGER 
DIRECTOR
DICERNA PHARMACEUTICALS INC   |  ADVANDX, INC.   |  QUOIN PHARMACEUTICALS, INC.
JONATHAN 
 
MACQUITTY 
DIRECTOR
DICERNA PHARMACEUTICALS INC   |  GYNESONICS, INC   |  PERSONALIS, INC.   |  LABCYTE INC   |  PALO ALTO HEALTH SCIENCES, INC.   |  FORTY SEVEN, INC.   |  D2G ONCOLOGY, INC.   |  ORCA BIOSYSTEMS INC
DAVID 
 
MADDEN 
EXECUTIVE OFFICER, DIRECTOR
DICERNA PHARMACEUTICALS INC   |  VAXART, INC.   |  NAVITOR PHARMACEUTICALS, INC.   |  HONOR CREMATIONS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-08-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-30 
2010-10-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-08-05 
2010-08-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-08-05 
2010-06-28
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2010-06-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#